
Kayra Innopharm Private Limited
About Kayra Innopharm Private Limited
Data last updated:
Kayra Innopharm Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2018PTC337261. Its GSTIN is 07AAHCK2178B1ZQ (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pragya Arora and Kushagra Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 303 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.86 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹13.37 Lakh (net margin 7.2%) and EBITDA of ₹16.92 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 53% over five years.
As per MCA filings, the company has open charges of ₹6.07 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
Company details
Contact details
Kayra Innopharm Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No 303 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kayra Innopharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kayra Innopharm is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Kayra Innopharm Private Limited, buy the company report.
Financials of Kayra Innopharm Private Limited
FY 2025 filings availableKayra Innopharm Private Limited reported revenue of ₹1.86 Cr (up 47% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 47% growth in the latest year. EBITDA rose 234% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 7.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kayra Innopharm Private Limited, buy the company report.
Board of directors of Kayra Innopharm Private Limited
Kayra Innopharm has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pragya Arora | Director | 07 Aug 2018 | 8 Years 3 Months | Current |
| Kushagra Arora | Director | 07 Aug 2018 | 8 Years 3 Months | Current |
| Shiv Arora | Director | 01 Jul 2019 | 7 Years 4 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2024 | 100907428 | Hdfc Bank Limited | ₹6.07 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Kayra Innopharm Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (TRAFFIC CHALLAN) | Filed against the company by State | Disposed |
| District court, Bilaspur, Himachal Pradesh | Court case (Motor Vehc Act) | Filed against the company by State of HP | Disposed |
To see the full case history of Kayra Innopharm Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kayra Innopharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kayra Innopharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCK2178B1ZQ | Delhi | Active | 08 Dec 2018 |
To see the full GST registrations and return filing status of Kayra Innopharm Private Limited, buy the company report.
Recent activity
Kayra Innopharm Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Shiv Arora was appointed as Director on 01 Jul 2019.
Frequently asked questions
Kayra Innopharm is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 August 2018 (8+ years old) and is registered under CIN U52609DL2018PTC337261.
Kayra Innopharm has 3 current directors:
- Pragya Arora - Director
- Kushagra Arora - Director
- Shiv Arora - Director
The latest financial statements of Kayra Innopharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Kayra Innopharm is 07AAHCK2178B1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Kayra Innopharm is U52609DL2018PTC337261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kayra Innopharm has 2 court cases on record: 2 filed against it.
Kayra Innopharm was incorporated on 07 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Shiv Arora was appointed as Director on 01 Jul 2019. Kushagra Arora was appointed as Director on 07 Aug 2018. Pragya Arora was appointed as Director on 07 Aug 2018.
The registered office of Kayra Innopharm is at Flat No 303 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008.
Kayra Innopharm operates in the pharma industry, in the drug formulation and development segment.

